Prosecution Insights
Last updated: October 25, 2026

Jiangsu Healthy Life Innovation Medical Technology Co. Ltd.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Jiangsu Healthy Life Innovation Medical Technology Co. Ltd. has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are handled by 2 distinct examiners. Wu, Tong E is the busiest examiner and holds 1 pending action. The portfolio is concentrated within 1 distinct art unit, which suggests a focused technological scope.

This structure requires the company to manage separate examiner relationships while navigating the standards of a single art unit. Because both actions are in 1 distinct art unit, there may be opportunities to apply consistent technical arguments across both cases. Practitioners should focus on the specific requirements of the 2 distinct examiners to resolve the pending matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WU, TONG E 1 71.0% +15.2%
HOLTZCLAW, MICHAEL T. 1 78.0% +15.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18723189 TUMOR TREATING FIELD SYSTEM AND METHOD FOR APPLYING ALTERNATING CURRENT SIGNALS THEREOF WU, TONG E —
18696666 Tumor Electric Field Treatment System HOLTZCLAW, MICHAEL T. —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18723189 TUMOR TREATING FIELD SYSTEM AND METHOD FOR APPLYING ALTERNATING CURRENT SIGNALS THEREOF WU, TONG E —
18696666 Tumor Electric Field Treatment System HOLTZCLAW, MICHAEL T. —

Top Art Units

Art UnitApps
3796 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18723189 TUMOR TREATING FIELD SYSTEM AND METHOD FOR APPLYING ALTERNATING CURRENT SIGNALS THEREOF WU, TONG E 3796 §102§103§112 Non-Final OA — Pending Feb 14, 2025
18696666 Tumor Electric Field Treatment System HOLTZCLAW, MICHAEL T. 3796 §103§112Other Non-Final OA — Pending Oct 14, 2024

Managing Jiangsu Healthy Life Innovation Medical Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Jiangsu Healthy Life Innovation Medical Technology Co. Ltd. have?

Jiangsu Healthy Life Innovation Medical Technology Co. Ltd. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.

Which USPTO examiner handles the most Jiangsu Healthy Life Innovation Medical Technology Co. Ltd. applications?

Tong E Wu has the most, with 1 of Jiangsu Healthy Life Innovation Medical Technology Co. Ltd.'s pending office actions.

What technology area are Jiangsu Healthy Life Innovation Medical Technology Co. Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month